advertisement
Halimitabrizi M 20
Showing records 1 to 20 | Display all abstracts from Halimitabrizi M127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Zhu Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Zhao AT
American Journal of Ophthalmology 2025; 280: 120-129
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Moksha L
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Di Rosa I; Salowe R
American Journal of Ophthalmology 2025; 280: 120-129
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Salowe R
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Jin F
American Journal of Ophthalmology 2025; 280: 120-129
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Vrathasha V
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Jin F; Lee R
American Journal of Ophthalmology 2025; 280: 120-129
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Pham K; Pham K; Aibo MI
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Aibo MI
American Journal of Ophthalmology 2025; 280: 120-129
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Aibo MI
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Aibo MI
American Journal of Ophthalmology 2025; 280: 120-129
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Lee R
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Halimitabrizi M
American Journal of Ophthalmology 2025; 280: 120-129
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Halimitabrizi M
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Chow C
American Journal of Ophthalmology 2025; 280: 120-129
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Di Rosa I
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Zhu Y
American Journal of Ophthalmology 2025; 280: 120-129
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
O'Brien JM
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Addis V; Sankar PS; Ying GS; O'Brien JM
American Journal of Ophthalmology 2025; 280: 120-129
